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acid cycle and dicarboxylic acid shuttle by these compounds thereby
supporting the notion of impaired energymetabolism playing an important
role in the pathophysiology of cerebral organic acidurias.
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Introduction: PA occurs due to a deficiency of Propionyl CoA carbox-
ylase enzyme andMMA due to a deficit of Methylmalonyl CoAMutase
or their cofactors. The treatment is a protein-restricted diet, special
formula without methionine, threonine, valine and isoleucine (MTVI),
supplementation with L-Carnitine, biotin and B12.
Objective: To determine the impact of formulas without MTVI subsidized
by the PNAC.
Methodology: We compared pre and post PNAC data regarding calorie
intake, protein, MTVI, calcium, iron, zinc, anthropometry (weight and
height), ammonium level and acylcarnitines. Statistical analysis was
performed using SPSS.
Results: 11 patients were admitted with PA and 4MMA, age range between
2 and 18 years. There was a statistically significant difference in the contri-
bution of special formula (average of 1 ± 0.7gr/kg/día increased) and a
significant correlation with size. Also significant differences regarding sup-
plementation of L-carnitine, MTVI and minerals. The size increased by 5.6 ±
4.4 cm and weight increased by 3.4 ± 5.4 kg, significant differences when
compared with pre-admission.
Conclusion: Admission to the PNAC has positively impacted children
with PA and MMA, reflected in the size and weight gain. However long-
term evaluations are required.
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Background: Primary hyperoxaluria Type 1 (PH1) is a rare autosomal
recessive inborn error of glyoxylate metabolism, caused by a deficiency
of the liver-specific peroxisomal enzyme alanine:glyoxylate aminotrans-
ferase. The disorder results in overproduction and excessive urinary
excretion of oxalate, causing recurrent urolithiasis and nephrocalcinosis.
Patient and methods: The patient, a 38 year-old-woman, was referred
to our lab with severe arthritis in the hips and knees, calcinosis and stage
V chronic renal failure under hemodialysis.
No urine samples were available to perform organic acids analysis so
we studied patient plasma. Samples were extracted with ethylacetate
and analyzed by GC-MS.
Results: Plasmatic organic acids profile in two different samples revealed
a marked concentration of oxalate (131 and 125 μmol/L; controls: 0-5)
and glycolate (362 and 338 μmol/L; controls: 9-42). Glycerate concen-
tration was normal (17 and 15 μmol/L; controls: 0-24).
Conclusions: The usual biochemical indicator of PH1 is a persistently
and markedly elevated urine oxalate. In the absence of urine samples,
this biochemical diagnosis can also be done in plasma samples.
PH1 is a treatable organic aciduria and an early and accurate diagnosis
preserves renal function of the patients. So, it is important to screen for PH1
in patients with recurrent urolithiasis or unexplained renal insufficiency.
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Background: Magnetic resonance spectroscopy (MRS) has been de-
scribed as a potential functional non-invasive neuroimaging technique
to detect neurologic striatal injury in patients with glutaric aciduria type I
(GA-1). Decreased N-acetyl-aspartate/creatinine ratio (NAA/Cr) has been
seen as a marker for reduction in neuronal integrity and neuronal loss, seen
in the majority of GA-1 patients with encephalopathic crises.
Objectives: To understand the MRS abnormalities associated with striatal
andwhitematter injury inGA-1 patients with theManitoba variant of GA-1
Method: 8 Manitoba patients with GA-1 underwent a total of 11 single-
voxel hydrogen MRS.
Results: 2 asymptomatic patients without encephalopathic crisis had
normal MRS. Only 1 out of 3 patients in our cohort demonstrated
decreased NAA/Cr on MRS during encephalopathic crisis. 3 more
patients had a history of significant encephalopathic crises 7-15 years
prior to their MRS and had normal NAA/Cr.
Conclusion: Although decreased NAA/Cr can be seen in MRS of GA-1
patients during an encephalopathic crisis, it does not appear to be a
consistent feature in our small cohort. Contrary to previous hypothesis,
the absence of decreased NAA/Cr in chronic symptomatic patients
suggests that decreased NAA/Cr is a marker for acute biochemical
disturbance rather than differential neuronal loss in GA-1.
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Background: Glutaric Aciduria type l is an autosomal recessive disorder
caused by mutations in glutaryl-Co A dehydrogenase gene(GCDH). Al-
though newborn screening can reduce adverse outcomes, it is not done in
Iran.We investigated clinical and genetic aspects of 6 Iranian GA-1 patients.
Methods: The diagnosis was made by urinary organic acid and/or
acylcarnitine analysis .Genomic DNA was extracted from peripheral
blood lymphocytes.
Results: Six Patients'(4 ♂,2♀) mean diagnosis age was 6.5±1.6 yrs. All 4
couples were first cousin. Presentations: Macrocephaly6/6, Developemental
Delay /Regression & Dystonia 4/6, Normal Development 2/6. MRI: Hydro-
cephaly 6/6, Frontotemporal Atrophy4/6, Temporal fossa arachnoid cysts2/6 .
Mean urineGlutaric acid ,3-OHGlutaric acid levels: 2051.5± 1026,29.5±19.4
mmol/molcr. respectively. DNA analysis: 2 siblings homozygote 181G>C,
One homozygote 881G>A,One heterozygote 1204C>T&707T>C, the other
2 sibling results are pending. Except one previously reported mutation
(1204C>T byBierly et al 1996) others were new in Iran. After therapy among
4 symptomatic patients the heterozygote one had repeated metabolic acidosis
attacks and others remained unchanged.
Conclusion: Our study indicates necessity of newborn screening to
lower diagnosis age of GA-1 in Iran, also suggests that different pre-
sentation and treatment response may be due to mutation diversity
which should be noted in therapy and genetic consultation.
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